Professor Brian MacCraith:

I thank Deputy Burke for his question. We would be slightly more hopeful than the Deputy that it might happen in April, even, at best, perhaps late March. These things are not predictable. The key point relates to the early results that we expect to hear in the next ten days or so in terms of their clinical trials.

Ireland, through the advance purchase agreement, has signed up at this stage to 2.2 million doses and they will be distributed across quarters 2, 3 and 4 of this year with the estimated peak in quarter 3, but we would expect, perhaps, in quarter 2, to have many hundreds of thousands. Again, these things are uncertain. That would be good news and all of those single doses would be single individuals not having to come back for a second dose.